Online Platform Scrutiny Continues as Congress Reviews Section 230

Posted by in State and Federal Regulatory Issues

Graphic with computer and technology symbols

As has been reported extensively over the last several months, the coronavirus disease 2019 (COVID-19) pandemic has presented an opportunity for criminals to leverage international fear and uncertainty for profit. Even predating the declaration of a national health emergency by the Trump Administration in March 2020, the United States Food and Drug Administration (FDA) and […]

Read More ›

Pharmacy Community Pulls Together To Combat COVID-19

Posted by in Boards of Pharmacy and NABP, State and Federal Regulatory Issues

Graphic of pharmacist wearing a mask

Challenging government and civil society at all levels, the COVID-19 pandemic has tested the ability of public officials, local and federal agencies, health care entities, and numerous other stakeholders to act quickly and effectively in a public health crisis. Because pharmacists play such an important role as frontline and accessible health care providers, numerous organizations […]

Read More ›

How Washington’s Response to COVID-19 Impacts Pharmacy Practice

Posted by in State and Federal Regulatory Issues

Graphic showing pharmacy elements during COVID-19

As the nation and the world contended with the emergence and spread of COVID-19 this spring, policymakers in Washington responded with unprecedented speed by enacting and implementing multiple sweeping laws and regulations to combat the virus. From major cash assistance for businesses and individuals to sweeping healthcare reforms, the COVID-19 public health emergency drove policies […]

Read More ›

Unclear CBD Legislation Keeps Regulators on Edge

Posted by in State and Federal Regulatory Issues

Graphic image showing CBD products and regulations

Since the passage of the 2018 Farm Bill, CBD-infused food and drink products have taken the marketplace by storm. You’ve probably seen it yourself in the grocery store – shelves featuring chocolate, tea, candy, and other edibles containing cannabidiol. These products are often impermissibly marketed to treat everything from anxiety to joint pain to cancer. […]

Read More ›

Increasing Access to Naloxone Can Be a Lifeline in the Community

Posted by in Consumer Protection, Pharmacies and Pharmacists, State and Federal Regulatory Issues

Image of naloxone medication information

If it weren’t for naloxone, many Americans would not be alive today. From 1996 to June 2014, at least 26,000 opioid overdoses were reversed with naloxone provided by community-based organizations. Naloxone access laws correlate with a 9 to 11 percent reduction in opioid-related deaths by state. In 2017, 70,237 Americans died from drug overdoses, and […]

Read More ›

Arkansas Inspector Ensures Pharmacies Are Up to Code

Posted by in State and Federal Regulatory Issues

Headshot of Kevin Robertson

Inspectors/investigators are the eyes and ears for boards of pharmacy, ensuring compliance with pharmacy law and practice standards. In this feature, inspectors reveal what they’ve learned in the field. Kevin Robertson, PharmD, PD, BCPS Inspector/Investigator, Arkansas State Board of Pharmacy How long have you been serving as an inspector for the Board? What was your […]

Read More ›
Page 3 of 3
1 2 3